Simulations Plus develops software for drug discovery and development using AI and machine learning technology. The company operates through two segments: Software and Services. Products include GastroPlus, DDDPlus, MembranePlus, and others that simulate molecular properties and predict toxicity. The company also offers products like Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor and MedChem Designer for modeling and simulation. Consulting services include population pharmacokinetic modeling, clinical trial simulations, and technical writing. The company serves pharmaceutical, biotech, agrochemical, cosmetics, food industry companies, and academic and regulatory agencies.
| Indicator | Value |
|---|---|
| PER | 29.1 |
| EV/EBITDA | 28.4 |
| Price/Free Cash Flow' | 32.1 |
| ROIC | 7.3% |
| Net Debt/EBITDA | -0.9 |